University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma

Simple item page
dc.contributor.authorGurnell, Mark
dc.contributor.authorDomingo, Christian
dc.contributor.authorRabe, Klaus F
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorPrice, David
dc.contributor.authorBrusselle, Guy
dc.contributor.authorWechsler, Michael E
dc.contributor.authorXia, Changming
dc.contributor.authorPandit-Abid, Nami
dc.contributor.authorGall, Rebecca
dc.contributor.authorJacob-Nara, Juby A.
dc.contributor.authorRowe, Paul J.
dc.contributor.authorDeniz, Yamo
dc.contributor.authorSiddiqui, Shahid
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2024-09-23T11:01:01Z
dc.date.available2024-09-23T11:01:01Z
dc.date.issued2022-10-31
dc.descriptionAcknowledgments and funding sources Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02528214 (VENTURE)/NCT02134028 (TRAVERSE). Medical writing/editorial assistance was provided by Éilis Sutton, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals, Inc., according to the Good Publication Practice guideline.en
dc.description.statusPeer revieweden
dc.format.extent135769
dc.identifier292442560
dc.identifierbd68dc43-7903-4f08-b6fe-cddc5f0ffbde
dc.identifier.citationGurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma', Chest, vol. 162, no. 4, Supplement, pp. A1909-A1913. https://doi.org/10.1016/j.chest.2022.08.1587en
dc.identifier.doi10.1016/j.chest.2022.08.1587
dc.identifier.iss4en
dc.identifier.issn0012-3692
dc.identifier.otherRIS: urn:A9CB50D11FB0D572E9371C3A18934ABD
dc.identifier.urihttps://hdl.handle.net/2164/24274
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0012369222029476en
dc.identifier.vol162en
dc.language.isoeng
dc.relation.ispartofChesten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleDupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthmaen
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gurnell_etal_CHEST_Dupilumab_Treatment_Leads_AAM.pdf
Size:
132.59 KB
Format:
Adobe Portable Document Format
Download

Collections

All research